For help on how to get the results you want, see our search tips.
2 results
Medicine
Paediatric investigation plans Remove Paediatric investigation plans filter
Referrals Remove Referrals filter
Referral safety status
Yes Remove Yes filter
-
List item
Referral: Janus Kinase inhibitors (JAKi) (updated)
tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 10/11/2022, Last updated: 15/11/2022 -
List item
Referral: Synchron
Article 31 referrals
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 19/05/2022, Last updated: 16/09/2022